capromab-pendetide and Neuroendocrine-Tumors

capromab-pendetide has been researched along with Neuroendocrine-Tumors* in 1 studies

Other Studies

1 other study(ies) available for capromab-pendetide and Neuroendocrine-Tumors

Article	Year
Next generation of targeted radiotherapy drugs emerging from the clinical pipeline. Journal of the National Cancer Institute, 2004, Jun-16, Volume: 96, Issue:12 Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bone Neoplasms; Clinical Trials as Topic; Disease Progression; Humans; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms; Neuroendocrine Tumors; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Radiation-Sensitizing Agents; Radiopharmaceuticals; Receptors, Peptide; Strontium	2004

Article

Year

Next generation of targeted radiotherapy drugs emerging from the clinical pipeline.

Journal of the National Cancer Institute, 2004, Jun-16, Volume: 96, Issue:12

Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bone Neoplasms; Clinical Trials as Topic; Disease Progression; Humans; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms; Neuroendocrine Tumors; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Radiation-Sensitizing Agents; Radiopharmaceuticals; Receptors, Peptide; Strontium

2004